Liposomal Nanoparticles Control the Uptake of Ciprofloxacin Across Respiratory Epithelia

[1]  B. Rubin,et al.  Aerosolized Antibiotics for Non-Cystic Fibrosis Bronchiectasis , 2014, Respiration.

[2]  H. Chan,et al.  Mannitol delivery by vibrating mesh nebulisation for enhancing mucociliary clearance. , 2011, Journal of pharmaceutical sciences.

[3]  M. Bebawy,et al.  Epithelial Profiling of Antibiotic Controlled Release Respiratory Formulations , 2011, Pharmaceutical Research.

[4]  M. Bebawy,et al.  Time- and passage-dependent characteristics of a Calu-3 respiratory epithelial cell model , 2010, Drug development and industrial pharmacy.

[5]  Abdelwahab Omri,et al.  Characterization of the interaction between liposomal formulations and Pseudomonas aeruginosa , 2010, Journal of liposome research.

[6]  Z. Drulis-Kawa,et al.  Liposomes as delivery systems for antibiotics. , 2010, International journal of pharmaceutics.

[7]  D. Geller.  Aerosol antibiotics in cystic fibrosis. , 2009, Respiratory care.

[8]  C. Dumouchel,et al.  Light multiple scattering correction of laser-diffraction spray drop-size distribution measurements , 2009 .

[9]  G. P. Martin,et al.  The permeability of large molecular weight solutes following particle delivery to air-interfaced cells that model the respiratory mucosa. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[10]  Robert Gurny,et al.  Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[11]  G. James,et al.  Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections. , 2008, The Journal of antimicrobial chemotherapy.

[12]  J. Gubernator,et al.  IN VITRO ANTIMICROBIAL ACTIVITY OF LIPOSOMES CONTAINING CIPROFLOXACIN, MEROPENEM AND GENTAMICIN AGAINST GRAM-NEGATIVE CLINICAL BACTERIAL STRAINS , 2007 .

[13]  T. Murray,et al.  Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients , 2007, Current opinion in pediatrics.

[14]  S. Newman.  Respiratory Drug Delivery X , 2006, Expert opinion on drug delivery.

[15]  Ben Forbes,et al.  Culture of Calu-3 Cells at the Air Interface Provides a Representative Model of the Airway Epithelial Barrier , 2006, Pharmaceutical Research.

[16]  Abdelwahab Omri,et al.  Mechanism of Enhanced Activity of Liposome-Entrapped Aminoglycosides against Resistant Strains of Pseudomonas aeruginosa , 2006, Antimicrobial Agents and Chemotherapy.

[17]  H. Wachtel,et al.  Comparison of cascade impaction and laser diffraction for particle size distribution measurements. , 2005, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[18]  C. Lehr,et al.  Cell culture models of the respiratory tract relevant to pulmonary drug delivery. , 2005, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[19]  C. Ehrhardt,et al.  Salbutamol is actively absorbed across human bronchial epithelial cell layers. , 2005, Pulmonary pharmacology & therapeutics.

[20]  E. Shore,et al.  A pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis. , 2005, Chest.

[21]  Huiming Yang,et al.  Liposome delivery of ciprofloxacin against intracellular Francisella tularensis infection. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[22]  M. T. ten Kate,et al.  Improved Efficacy of Ciprofloxacin Administered in Polyethylene Glycol-Coated Liposomes for Treatment of Klebsiella pneumoniae Pneumonia in Rats , 2001, Antimicrobial Agents and Chemotherapy.

[23]  M. Fresta,et al.  Ofloxacin-Loaded Liposomes: In Vitro Activity and Drug Accumulation in Bacteria , 2000, Antimicrobial Agents and Chemotherapy.

[24]  K. Lohner,et al.  Differential scanning calorimetry and X-ray diffraction studies of the specificity of the interaction of antimicrobial peptides with membrane-mimetic systems. , 1999, Biochimica et biophysica acta.

[25]  R. Hancock.  Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  M. Hope,et al.  Antibacterial Efficacy against an In Vivo Salmonella typhimurium Infection Model and Pharmacokinetics of a Liposomal Ciprofloxacin Formulation , 1998, Antimicrobial Agents and Chemotherapy.

[27]  M. Cavet,et al.  Transepithelial transport of the fluoroquinolone ciprofloxacin by human airway epithelial Calu-3 cells , 1997, Antimicrobial agents and chemotherapy.

[28]  P. Shek.  Liposomes in Biomedical Applications , 1995 .

[29]  A. Clark.  The use of laser diffraction for the evaluation of the aerosol clouds generated by medical nebulizers , 1995 .

[30]  P. Byron.  Respiratory Drug Delivery , 1989 .

[31]  R. Hancock,et al.  Expression in Escherichia coli and function of Pseudomonas aeruginosa outer membrane porin protein F , 1986, Journal of Bacteriology.

[32]  E. Bruck,et al.  National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.

[33]  P. Bruinenberg,et al.  Safety, tolerability, pharmacokinetics and antimicrobial activity of inhaled liposomal ciprofloxacin formulations in humans , 2010 .

[34]  C. Ehrhardt,et al.  Drug absorption by the respiratory mucosa: cell culture models and particulate drug carriers. , 2002, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[35]  P. Diot,et al.  Validation of laser diffraction method as a substitute for cascade impaction in the European Project for a Nebulizer Standard. , 2001, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[36]  Kenneth Meyer,et al.  Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis. , 2000, American journal of respiratory and critical care medicine.